These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8968966)

  • 1. Relationship between beta adrenoceptor occupancy and receptor down-regulation induced by beta antagonists with intrinsic sympathomimetic activity.
    Lima JJ
    J Recept Signal Transduct Res; 1996; 16(5-6):357-72. PubMed ID: 8968966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of beta-adrenergic receptor blockers with intrinsic sympathomimetic activity.
    Jasper JR; Michel MC; Insel PA
    FASEB J; 1988 Oct; 2(13):2891-4. PubMed ID: 2901994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
    Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity.
    Thulesius O; Gjöres JE; Berlin E
    Br J Clin Pharmacol; 1982; 13(Suppl 2):229S-230S. PubMed ID: 6125174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
    Jakubetz J; Schmuck S; Poller U; Fuchs B; Gorf A; Radke J; Pönicke K; Brodde OE
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):461-72. PubMed ID: 10069683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
    Brodde OE; Schemuth R; Brinkmann M; Wang XL; Daul A; Borchard U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):130-8. PubMed ID: 2875397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of (+/-)-, (+)- and (-)-celiprolol and bromoacetylalprenololmentane at the beta-adrenoceptors of rat isolated cardiovascular preparations.
    Doggrell SA
    J Pharm Pharmacol; 1990 May; 42(5):319-24. PubMed ID: 1976778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats.
    Nanoff C; Ströher M; Haschkowitz H; Schütz W; Pittner H
    Basic Res Cardiol; 1990; 85(1):88-95. PubMed ID: 1970235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat.
    Abrahamsson T
    Br J Pharmacol; 1986 Apr; 87(4):657-64. PubMed ID: 2871880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
    Uprichard AC; Chi LG; Kitzen JM; Lynch JJ; Frye JW; Lucchesi BR
    J Pharmacol Exp Ther; 1989 Nov; 251(2):571-7. PubMed ID: 2572693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
    Neve KA; Barrett DA; Molinoff PB
    J Pharmacol Exp Ther; 1985 Dec; 235(3):657-64. PubMed ID: 2867205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
    Jasper JR; Motulsky HJ; Insel PA
    J Pharmacol Exp Ther; 1988 Mar; 244(3):820-4. PubMed ID: 2908047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Certain beta-blockers can decrease beta-adrenergic receptor number: II. Down-regulation of receptor number by alprenolol and propranolol in cultured lymphoma and muscle cells.
    Hughes RJ; Mahan LC; Insel PA
    Circ Res; 1988 Aug; 63(2):279-85. PubMed ID: 2899462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative potencies of various beta-adrenoceptor antagonists (BAA) at the level of the human myocardial beta-adrenoceptor-adenylate cyclase (AC) complex. Is intrinsic sympathomimetic activity (ISA) due to AC activation?
    Golf S; Hansson V
    Scand J Clin Lab Invest; 1986 Apr; 46(2):121-30. PubMed ID: 2872714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of celiprolol.
    Louis WJ; Drummer OH; Tung LH
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1281-5. PubMed ID: 1672604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-adrenoceptor antagonist administration on beta 2-adrenoceptor density in human lymphocytes. The role of the "intrinsic sympathomimetic activity".
    Brodde OE; Daul A; Stuka N; O'Hara N; Borchard U
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):417-22. PubMed ID: 2859531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects of beta adrenoceptor agonists and antagonists on the rat ovarian suspensory ligament.
    Stanton HC; Dungan KW
    J Pharmacol Exp Ther; 1986 Nov; 239(2):591-6. PubMed ID: 2877087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Certain beta-blockers can decrease beta-adrenergic receptor number: I. Acute reduction in receptor number by tertatolol and bopindolol.
    De Blasi A; Fratelli M; Marasco O
    Circ Res; 1988 Aug; 63(2):273-8. PubMed ID: 2899461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.